Stasiowski Michał Jan, Lyssek-Boroń Anita, Krysik Katarzyna, Majer Dominika, Zmarzły Nikola, Grabarek Beniamin Oskar
Chair and Department of Emergency Medicine, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland.
Department of Ophthalmology, St. Barbara Hospital, Trauma Centre, 41-200 Sosnowiec, Poland.
Biomedicines. 2024 Oct 10;12(10):2303. doi: 10.3390/biomedicines12102303.
BACKGROUND/OBJECTIVES: Precisely selected patients require vitreoretinal surgeries (VRS) performed under general anesthesia (GA) when intravenous rescue opioid analgesics (IROA) are administered intraoperatively, despite a risk of adverse events, to achieve hemodynamic stability and proper antinociception and avoid the possibility of intolerable postoperative pain perception (IPPP). Adequacy of anesthesia guidance (AoA) optimizes the titration of IROA. Preventive analgesia (PA) techniques and intravenous or preoperative peribulbar block (PBB) using different local anesthetics (LAs) are performed prior to GA to optimize IROA. The aim was to analyze the utility of PBBs compared with intravenous paracetamol added to AoA-guided GA on the incidence of IPPP and hemodynamic stability in patients undergoing VRS.
A total of 185 patients undergoing vitreoretinal surgery (VRS) were randomly assigned to one of several anesthesia protocols: general anesthesia (GA) with analgesia optimized through AoA-guided intraoperative remifentanil opioid analgesia (IROA) combined with a preemptive single dose of 1 g of paracetamol (P group), or PBB using one of the following options: 7 mL of an equal mixture of 2% lidocaine and 0.5% bupivacaine (BL group), 7 mL of 0.5% bupivacaine (BPV group), or 7 mL of 0.75% ropivacaine (RPV group). According to the PA used, the primary outcome measure was postoperative pain perception assessed using the numeric pain rating scale (NPRS), whereas the secondary outcome measures were as follows: demand for IROA and values of hemodynamic parameters reflecting quality or analgesia and hemodynamic stability.
A total of 175 patients were finally analyzed. No studied PA technique proved superior in terms of rate of incidence of IPPP, when IROA under AoA was administered ( = 0.22). PBB using ropivacaine resulted in an intraoperative reduction in the number of patients requiring IROA ( = 0.002; < 0.05) with no influence on the dose of IROA ( = 0.97), compared to paracetamol, and little influence on hemodynamic stability of no clinical relevance in patients undergoing VRS under AoA-guided GA.
PA using paracetamol or PBBs, regardless of LAs used, in patients undergoing VRS proved no advantage in terms of rate of incidence of IPPP and hemodynamic stability when AoA guidance for IROA administration during GA was utilized. Therefore, PA using them seems no longer justified due to the potential, although rare, side effects.
背景/目的:经过精确筛选的患者在全身麻醉(GA)下进行玻璃体视网膜手术(VRS)时,尽管存在不良事件风险,但术中仍需给予静脉补救性阿片类镇痛药(IROA),以实现血流动力学稳定和适当的镇痛效果,并避免出现难以忍受的术后疼痛感知(IPPP)。麻醉指导的充分性(AoA)可优化IROA的滴定。在全身麻醉之前,采用预防性镇痛(PA)技术以及使用不同局部麻醉药(LA)进行静脉或术前球周阻滞(PBB),以优化IROA。本研究旨在分析在接受VRS的患者中,与在AoA指导下的全身麻醉中添加静脉注射对乙酰氨基酚相比,PBB在IPPP发生率和血流动力学稳定性方面的效用。
总共185例接受玻璃体视网膜手术(VRS)的患者被随机分配至以下几种麻醉方案之一:通过AoA指导的术中瑞芬太尼阿片类镇痛药(IROA)联合1 g对乙酰氨基酚的预充剂量进行优化镇痛的全身麻醉(GA)(P组),或采用以下方法之一进行PBB:7 mL 2%利多卡因和0.5%布比卡因的等量混合物(BL组)、7 mL 0.5%布比卡因(BPV组)或7 mL 0.75%罗哌卡因(RPV组)。根据所使用的PA,主要结局指标是使用数字疼痛评分量表(NPRS)评估的术后疼痛感知,而次要结局指标如下:IROA的需求量以及反映镇痛质量和血流动力学稳定性的血流动力学参数值。
最终共分析了175例患者。当在AoA指导下给予IROA时,没有一种研究的PA技术在IPPP发生率方面表现出优越性(P = 0.22)。与对乙酰氨基酚相比,使用罗哌卡因进行PBB可使术中需要IROA的患者数量减少(P = 0.002;P < 0.05),且对IROA的剂量没有影响(P = 0.97),并且在AoA指导的GA下接受VRS的患者中,对血流动力学稳定性几乎没有临床相关影响。
在接受VRS的患者中,当在GA期间对IROA给药采用AoA指导时,使用对乙酰氨基酚或PBB进行PA在IPPP发生率和血流动力学稳定性方面均未显示出优势。因此,由于存在潜在的(尽管罕见)副作用,使用它们进行PA似乎不再合理。